Aligos Therapeutics Inc. (ALGS) NASDAQ

$0.98 (0.04) (-4.02%)

Market Cap: $74.08M

As of 03/27/24 04:00 PM EDT. Market closed.

(ALGS)

Aligos Therapeutics Inc. (ALGS)
NASDAQ

$0.98
(0.04) (-4.02%)

Market Cap: $74.08M

As of 03/27/24 04:00 PM EDT. Market closed.

Add to Portfolio

aligos therapeutics, inc., a biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. its lead drug candidate is alg-010133, a synthetic oligonucleotide that is in phase i clinical trial for the treatment of chronic hepatitis b (chb). the company is also developing alg-000184, a capsid assembly modulator to treat chb; alg-020572, ... read more

aligos therapeutics, inc., a biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. its lead drug candidate is alg-010133, a synthetic oligonucleotide that is in phase i clinical trial for the treatment of chronic hepatitis b (chb). the company is also developing alg-000184, a capsid assembly modulator to treat chb; alg-020572, a oligonucleotide for the treatment of chb; alg-125097, an sirna drug candidate to treat chb; and alg-055009, a small molecule thr-ã? agonist for the treatment of non-alcoholic steatohepatitis. aligos therapeutics, inc. was founded in 2018 and is headquartered in south san francisco, california. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
85
Address
.
PRICE CHART FOR ALIGOS THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1
Previous Close
$1.02
Days Range
$0.95 - $1
52 week range
$0.54 - $1.38
Volume
646,945
Avg. Volume (30 days)
506,871
Market Cap
$74.08M
Dividend Yield
-
P/E
(0.84)
Shares Outstanding
75,668,521
Open
$1
Previous Close
$1.02
Days Range
$0.95 - $1
52 week range
$0.54 - $1.38
Volume
646,945
Avg. Volume (30 days)
506,871
Market Cap
$74.08M
Dividend Yield
-
P/E
(0.84)
Shares Outstanding
75,668,521
FINANCIAL STATEMENTS FOR ALIGOS THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ALIGOS THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Nuechterlein CaroleDirectorOct 25, 2023 Buy$0.767,933,6016,004,14911,025,941Oct 27, 2023, 04:15 PM
BLATT LAWRENCEChief Executive OfficerOct 25, 2023 Option Exercise$0.76610,277461,8581,847,575Oct 27, 2023, 04:14 PM
Scopa James PaulDirectorOct 25, 2023 Option Exercise$0.76183,083138,557183,083Oct 27, 2023, 04:13 PM
Novo Holdings A/S10% OwnerOct 20, 2020 Buy$15.00200,0003,000,0002,614,563Oct 22, 2020, 04:31 PM
Woiwode ThomasDirectorOct 20, 2020 Buy$15.00200,0003,000,000862,444Oct 20, 2020, 05:00 PM
Vivo Capital VIII, LLC10% OwnerOct 20, 2020 Buy$15.0066,7331,000,995430,372Oct 20, 2020, 04:59 PM
Vivo Capital VIII, LLC10% OwnerOct 20, 2020 Buy$15.00483,2677,249,0053,116,658Oct 20, 2020, 04:59 PM
Versant Venture Capital VI, L.P.10% OwnerOct 20, 2020 Buy$15.00200,0003,000,000862,444Oct 20, 2020, 04:58 PM
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Nuechterlein CaroleDirector10/25/20236,004,149
BLATT LAWRENCEChief Executive Officer10/25/2023461,858
Scopa James PaulDirector10/25/2023138,557
Novo Holdings A/S10% Owner10/20/20203,000,000
Woiwode ThomasDirector10/20/20203,000,000
Vivo Capital VIII, LLC10% Owner10/20/20201,000,995
Vivo Capital VIII, LLC10% Owner10/20/20207,249,005
Versant Venture Capital VI, L.P.10% Owner10/20/20203,000,000
FUNDS WITH A POSITION IN ALIGOS THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
VIVO CAPITAL, LLC3,547,0300.19%No changeOther
HHLR ADVISORS, LTD.1,906,1910.03%-17.47%Other
BAKER BROS. ADVISORS LP2,076,4000.02%No changeOther
ADAGE CAPITAL PARTNERS GP, L.L.C.1,223,2780.00207%ExitedOther
RENAISSANCE TECHNOLOGIES LLC489,9600.0005%52.46%Other
GEODE CAPITAL MANAGEMENT, LLC321,0440.00002%32.94%Other
BLACKROCK INC.296,1390.00001%-0.28%Other
CHANGE IN SHARES OUTSTANDING FOR ALIGOS THERAPEUTICS INC
STOCK BUYBACKS FOR ALIGOS THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2022
50.28%
5Q
12/31/2023
06/30/2022
50.61%
6Q
12/31/2023
03/31/2022
51.16%
7Q
12/31/2023
12/31/2021
53.12%
8Q
12/31/2023
09/30/2021
51.56%
9Q
12/31/2023
06/30/2021
70.82%
10Q
12/31/2023
03/31/2021
71.66%
11Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2022
50.28%
5Q
06/30/2022
50.61%
6Q
03/31/2022
51.16%
7Q
12/31/2021
53.12%
8Q
09/30/2021
51.56%
9Q
06/30/2021
70.82%
10Q
03/31/2021
71.66%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ALIGOS THERAPEUTICS INC
LOADING...